세계 요역동학 장치 시장 규모는 2023년 4억 335만 달러에 달했습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 6.03%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 5억 7,316만 달러에 달할 것으로 예측됩니다. 신장 질환의 유병률 증가, 방광암의 유병률 증가, 요역동학 장치의 기술 발전 등이 2024년부터 2030년까지 예측 기간 동안 요역동학 장치 시장의 성장에 기여하고 있습니다.
신장 질환의 유병률 증가는 요역동학 장치 시장의 주요 촉진요인입니다.
예를 들어, 2020년 세계 신장의 날 조직에 따르면, 신장 질환은 전 세계 약 8억 5,000만 명이 앓고 있는 비전염성 질환입니다. 같은 소식통에 따르면 성인 10명 중 1명이 만성 신장 질환을 앓고 있으며, 2040년까지 전 세계적으로 5번째로 많은 생명을 잃는 원인이 될 것으로 예상하고 있습니다.
미국 신장재단(National Kidney Foundation)의 2022년 발표에 따르면 2020년 전 세계 인구의 약 10%가 만성 신장 질환을 앓고 있으며, 저렴한 치료법을 충분히 이용할 수 없어 매년 수백만 명이 사망하고 있다고 합니다. 자료에 따르면 2020년 약 200만 명 이상이 투석이나 신장 이식 치료를 받고 있지만, 이 수치는 생존을 위해 치료가 필요한 사람들의 10%에 불과합니다.
미국 질병통제예방센터(Centers for Disease Control and Prevention 2022)에 따르면, 2020년에는 미국인 7명 중 1명 이상, 즉 15%에 해당하는 3,700만 명이 만성 신장 질환을 앓고 있는 것으로 추산됩니다.
Kidney Care UK에 따르면 2020년 영국에서 약 300만 명이 만성 신장 질환을 앓고 있다고 합니다. 또한, 영국에서는 매년 약 40-45,000명이 만성콩팥병으로 인해 조기 사망하고 있다고 합니다.
따라서 신장 질환의 유병률 증가는 요역동학 장치에 대한 수요를 증가시켜 요역동학 장치 시장의 성장에 박차를 가할 것으로 예상됩니다.
이 보고서는 세계 요역동학 기기 시장을 조사했으며, 시장 개요와 함께 제품 유형별, 최종사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps And Transducer Sets, Others), By End-User (Hospitals And Urology Clinics, Ambulatory Surgery Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of kidney disorders, increasing prevalence of bladder cancers
Global Urodynamic Devices Market was valued at USD 403.35 Million in 2023, growing at a CAGR of 6.03% during the forecast period from 2024 to 2030 to reach USD 573. 16 Million by 2030. The Urodynamic Devices market is witnessing positive growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2024-2030.
Urodynamic Devices Market Dynamics:
The rising prevalence of kidney disorders is the key driving factor for the Urodynamic Devices market.
For instance, as per the World Kidney Day organization in 2020, kidney disease is a non-communicable disease affecting about 850 million people across the world. as per the same source, about one in ten adults are observed to be suffering from chronic kidney disease which is projected to become the fifth most common cause of life loss globally by the year 2040.
As per the National Kidney Foundation 2022, in 2020 about 10% of the population globally suffered from chronic kidney diseases and millions of people were dying every year as they did not have enough access to affordable treatments. As per the same source, about over 2 million people had received treatment with dialysis or kidney transplant in the year 2020 but this number represents only 10% of the people requiring treatment to stay alive.
According to the Centers for Disease Control and Prevention 2022, more than one in seven, that is 15% of the US people or 37 million people were estimated to be have suffered from chronic kidney disorders in the year 2020.
As per the Kidney Care UK in 2020, around 3 million people in the United Kingdom were suffering from chronic kidney diseases. Also as per the same source, there are about 40-45,000 premature deaths in the UK every year due to CKD.
Therefore, due to the rising prevalence of kidney disorders, there will be an increase in the demand for urodynamic devices, thereby fueling the market growth for Urodynamic Devices.
However, the high cost of the urodynamic devices and tests and complications associated with urodynamic catheters such as pain, patient anxiety, and injury may be certain limiting factors of the Urodynamic Devices market growth.
The unprecedented COVID-19 outbreak had a profound impact on the market for urodynamic devices. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patients visits, and all other surgical/diagnostic procedures were temporarily paused, giving more attention to the COVID-19 inflicted patients. However, as a result of relaxation observed in the COVID-19 lockdown and the approvals and launches in the urodynamic devices arena, there had been normalcy attained in the growth of the urodynamic devices market.
Urodynamic Devices Market Segment Analysis:
Urodynamic Devices Market By Product Type (Uroflowmetry Equipment, Electromyograph, Urodynamic Systems, Urodynamic Catheters, Urodynamic Pumps and Transducer Sets, Others), By End-User (Hospitals and Urology Clinics, Ambulatory Surgery Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Urodynamic Devices market, Electromyograph are estimated to hold a higher share in the Urodynamic Devices market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices.
The demand for electromyography devices will improve owing to the rising prevalence of kidney disorders and bladder cancers globally, the approval and launch of electromyography devices, and the increased research and development on electromyography devices.
For instance, as per the World Bladder Cancer Patient Coalition in the year 2020, about 573,278 people are suffering from bladder cancer globally. As per the same source, bladder cancer is considered the tenth most commonly diagnosed cancer in the world.
As per the National Institute of Health in the year 2020, the rate of new cases of bladder cancer was 19.7 per 100,000 men and women per year. As per the same source, approximately 2.4 percent of men and women will be diagnosed with bladder cancer at some point during their lifetime, based on 2016-2018 data.
Furthermore, according to the International Society of Nephrology 2022, in the year 2020 more than 850 million people were suffering from chronic kidney disorders.
Hence, all the aforementioned factors will contribute to the growth of electromyograph devices in Urodynamic Devices market.
North America is expected to dominate the overall Urodynamic Devices Market:
Among all the regions, North America is expected to account for the largest share in the Global Urodynamic Devices market. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country.
According to the National Institute of Health in the year 2020, 1 in 7 adults in the United States was suffering from chronic kidney disease. This accounts for a total of 37 million Americans.
Also, as per the Centers for Disease Control and Prevention 2022, in the year 2020 chronic kidney disorders are more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%) for the United States.
As per the American Journal of Kidney Diseases 2020, End-Stage Renal Disease (ESRD) prevalence in the United States remains one of the highest in the world at 2,242 cases per million population in 2018.
As per the American Cancer Society's estimates for bladder cancer in the United States in the year 2020, about 83,730 new cases of bladder cancer were diagnosed (about 64,280 in men and 19,450 in women).
Thus, all the above-mentioned factors are anticipated to propel the market for Urodynamic Devices in the United States region.
Urodynamic Devices Market Key Players:
Some of the key market players operating in the Urodynamic Devices market include B Braun Meslungen AG, BestMedical, MINZE HEALTH, Santron Meditronic., Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group®, HCItalia srl, DeltaMed, MEDICA S.P.A, Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd, Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd, and others.
Recent Developmental Activities in the Urodynamic Devices Market:
In March 2022, A video urodynamic lab was inaugurated at the Delhi government-run Lok Nayak Hospital by Health Minister. The lab is capable of taking real-time pictures of the urinary tract and bladder, which also provides immediate biofeedback.
Key Takeaways from the Urodynamic Devices Market Report Study
Target Audience who can be benefited from this Urodynamic Devices Market Report Study
Frequently Asked Questions for the Urodynamic Devices Market:
Urodynamic Devices are created to investigate the function of the urinary tract by taking physical measurements of bladder pressure and flow rates.
Global Urodynamic Devices Market was valued at USD 403.35 Million in 2023, growing at a CAGR of 6.03% during the forecast period from 2024 to 2030 to reach USD 573. 16 Million by 2030.
The Urodynamic Devices market is witnessing positive market growth owing to the rising prevalence of kidney disorders, increasing prevalence of bladder cancers, technological advancements in Urodynamic Equipment, thereby contributing to the growth of the Urodynamic Devices market during the forecast period from 2024-2030
Some of the key market players operating in the Urodynamic Devices market include B Braun Meslungen AG, BestMedical, MINZE HEALTH, Santron Meditronic., Potent Medical, Laborie, MEDKONSULT medical technology s.r.o., The Prometheus Group®, HCItalia srl, DeltaMed, MEDICA S.P.A, Aymed Medical Technology, EV.SERVICE ITALIA, tic Medizintechnik GmbH & Co. KG, Creo Medical Ltd, Stericom Ltd., Amecath Medical Technologies, Cook, Well Lead Medical Co., Ltd, and others.
North America is expected to hold the highest share in the revenue in the Urodynamic Devices market during the forecast period. The rising prevalence of renal disorders and urinary bladder cancers, growing products approvals, and launches along with favorable reimbursement policies are the key factor contributing to the Urodynamic Devices market in the country are expected to aid in the growth of the North America Urodynamic Devices Market.